In fiscal 2026, which ended Jan 31, 2026, Healthequity, Inc. generated $457.1 million of cash from operations, up 34.5% from the year before. It spent $2.0 million on capital expenditures. That left free cash flow of $455.1 million. The company returned $299.3 million in share buybacks to shareholders.
USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.
| Line |
FY 2027
Jul 31, 2026
|
FY 2026
Jan 31, 2026
|
FY 2025
Jan 31, 2025
|
FY 2024
Jan 31, 2024
|
FY 2023
Jan 31, 2023
|
FY 2022
Jan 31, 2022
|
FY 2021
Jan 31, 2021
|
FY 2020
Jan 31, 2020
|
FY 2019
Jan 31, 2019
|
FY 2018
Jan 31, 2018
|
FY 2017
Jan 31, 2017
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | |||||||||||
| Depreciation and amortization |
158
+0.3%
|
155
-4.8%
|
162
+6.1%
|
153
-5.0%
|
161
+17.5%
|
137
+18.4%
|
116
+109.4%
|
55
+204.4%
|
18
+14.0%
|
16
+21.0%
|
13
+53.3%
|
| Stock-based compensation |
81
+6.6%
|
73
-24.2%
|
96
+25.0%
|
77
+23.2%
|
63
+18.7%
|
53
+23.1%
|
43
+7.6%
|
40
+89.2%
|
21
+47.1%
|
14
+70.4%
|
8
+42.8%
|
| Operating cash flow |
490
+33.6%
|
457
+34.5%
|
340
+40.0%
|
243
+61.2%
|
151
+6.8%
|
141
-22.4%
|
182
+73.0%
|
105
-7.4%
|
113
+38.8%
|
82
+79.2%
|
46
+71.8%
|
| Investing | |||||||||||
| Capital expenditures |
2
+65.4%
|
2
-5.5%
|
2
+23.0%
|
2
-49.7%
|
3
-62.2%
|
9
-32.0%
|
13
+79.7%
|
7
+88.3%
|
4
-29.1%
|
5
+49.7%
|
4
+53.4%
|
| Investing cash flow |
-60
-11.0%
|
-47
+90.7%
|
-505
-997.0%
|
-46
+61.3%
|
-119
+81.4%
|
-639
-559.3%
|
-97
+94.4%
|
-1,740
-6885.0%
|
26
+169.8%
|
-37
-181.5%
|
-13
+85.6%
|
| Financing | |||||||||||
| Debt issued |
—
|
0
-100.0%
|
737
|
0
|
0
-100.0%
|
950
|
0
-100.0%
|
1,250
|
—
|
—
|
—
|
| Debt repaid |
77
-87.4%
|
100
-82.2%
|
562
+933.3%
|
54
+521.4%
|
9
-99.1%
|
1,003
+319.6%
|
239
+2959.8%
|
8
|
—
|
—
|
—
|
| Dividends paid |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
0
|
| Stock buybacks |
404
|
299
+146.3%
|
121
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
| Financing cash flow |
-479
-42.7%
|
-387
-772.2%
|
58
+222.4%
|
-47
-1661.1%
|
-3
-100.7%
|
395
+653.2%
|
52
-96.4%
|
1,466
+6292.5%
|
23
+57.4%
|
15
-38.7%
|
24
-35.1%
|
| Change in cash | |||||||||||
| Net change in cash |
-48
-116.0%
|
23
+121.3%
|
-108
-172.2%
|
150
+418.9%
|
29
+127.9%
|
-103
-175.4%
|
137
+180.8%
|
-170
|
—
|
—
|
—
|
| Free cash flow |
488
+33.5%
|
455
+34.7%
|
338
+40.1%
|
241
+63.7%
|
147
+11.5%
|
132
-21.6%
|
169
+72.5%
|
98
-10.8%
|
110
+43.7%
|
76
+81.8%
|
42
+73.6%
|
| Per share | |||||||||||
| Free cash flow per share |
5.69
+38.0%
|
5.20
+36.8%
|
3.80
+37.1%
|
2.77
+59.0%
|
1.74
+9.8%
|
1.59
-28.6%
|
2.23
+56.0%
|
1.43
-17.4%
|
1.73
+40.2%
|
1.23
+76.0%
|
0.70
+70.6%
|
| Shareholder returns | |||||||||||
| Returned to shareholders |
404
|
299
|
121
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
0
|
| Share of free cash flow |
82.94%
|
65.75%
|
35.97%
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
0.00%
|
| Ratios | |||||||||||
| Free cash flow margin |
35.81%
|
34.65%
|
28.15%
|
24.12%
|
17.09%
|
17.46%
|
22.97%
|
18.37%
|
38.14%
|
33.22%
|
23.52%
|
| Capital expenditures to revenue |
0.18%
|
0.15%
|
0.17%
|
0.17%
|
0.39%
|
1.18%
|
1.78%
|
1.37%
|
1.35%
|
2.38%
|
2.04%
|
| Stock-based compensation to revenue |
5.97%
|
5.56%
|
8.04%
|
7.72%
|
7.27%
|
6.97%
|
5.84%
|
7.49%
|
7.33%
|
6.23%
|
4.71%
|
| Cash conversion |
2.07x
|
2.12x
|
3.51x
|
4.36x
|
—
|
—
|
20.56x
|
2.65x
|
1.53x
|
1.73x
|
1.73x
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.
Company profile
- Industry
- Services-Business Services, NEC (SIC 7389)
- Listed as
- HQY (Nasdaq)
- Fiscal year ends
- January 31
- Incorporated in
- DE
- Headquarters
- Draper, UT
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1428336
- Former names
- HEALTHEQUITY INC (until Jun 6, 2019)
Other Services-Business Services, NEC companies
- Visa Inc. V
- Mastercard Inc MA
- Alibaba Group Holding Ltd BABA
- Accenture plc ACN
- Uber Technologies, Inc UBER
- PDD Holdings Inc. PDD
- Mercadolibre Inc MELI
- DoorDash, Inc. DASH
Source: SEC EDGAR filings. This is company-reported data, not investment advice.